Quality of Life Assessment in Patients Who Are Under Surveillance for IPMN
NCT ID: NCT03131076
Last Updated: 2017-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2017-05-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life in Patients With Multiple Myeloma
NCT00290095
Tumors of the Peripheral Nervous System
NCT05735548
Comparative Study Between Different Approaches to CPA-petroclival Meningiomas
NCT03462914
Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised
NCT04004377
Peripheral Primitive Fibromatosis
NCT01801176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study determines the effects of the surveillance on the patients quality of life and anxiety levels. The study will be conducted by 15D- quality of life -questionnaire and state-trait anxiety inventory (STAI) -questionaire. Both will be send to the patients before a IPMN follow up MRI and 3 months later. It is anticipated that the anxiety and the effect on the quality of life would be the highest right before the MRI and would normalize a few months after the MRI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IPMN follow up
Follow up with MRI and laboratory blood tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heini Nieminen
licensed physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heini Nieminen
Role: PRINCIPAL_INVESTIGATOR
Helsinki Universtity Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Nieminen H, Roine R, Ristimaki A, Lantto E, Valimaa N, Kirveskari E, Sintonen H, Haglund C, Seppanen H. Health-related quality of life and anxiety levels among patients under surveillance for intraductal papillary mucinous neoplasm. BMC Gastroenterol. 2023 Jan 16;23(1):14. doi: 10.1186/s12876-023-02639-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPMN Quality of life
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.